Skip to main content

Advertisement

Table 5 Distribution of Clinicopathological parameters in each molecular subtypes of breast cancer among the study participants

From: Breast cancer in Ethiopia: evidence for geographic difference in the distribution of molecular subtypes in Africa

Clinico-pathological Parameters Luminal A Luminal B HER2-enriched Triple Negative Total p-value
Median age at diagnosis(min-max) 47(22–75) 35(22–53) 41(27–65) 46(29–60)   0.009
Tumor grade, n (%)
 I 5(18) 0(0) 1(13) 1(6) 7(9)  
 II 11(39) 8(36) 5(63) 7(39) 31(41) 0.243
 III 12(43) 14(64) 2(25) 10(55) 38(50)  
Stage, n (%)
 I 9(24) 5(19) 1(11) 4(18) 19(20)  
 II 13(35) 13(48) 1(11) 9(41) 36(38) 0.632
 III 14(38) 8(30) 6(67) 8(36) 36(38)  
 IV 1(3) 1(4) 1(11) 1(5) 4(4)  
Histological type, n (%)
 Ductal 29(70) 15(60) 7(80) 17(80) 66(69) 0.708
 Lobular 2(10) 4(10) 0(0) 0(0) 6(6)
 Others/Unknown 9(20) 8(30) 2(20) 5(20) 24(25)